Dr. Dee Mangin’s Research Recognized for its Potential Impact on Clinical Practice
The Department of Family Medicine at McMaster University is pleased to announce that the North American Primary Care Research Group (NAPCRG) has recognized two recent studies by Dr. Dee Mangin for the significant potential each has to impact clinical practice. Just ten studies, called Pearls, were selected to receive the honour this year.
Given the breadth and quality of work presented at the annual NAPCRG meeting, it is a meaningful achievement for Dr. Mangin to have two papers chosen in a single year and to be the only Canadian researcher in the diverse group.
“The great hope of any researcher is for the results of their work to be used to improve patient care in day-to-day practice; these awards help increase the visibility and awareness of the work,” said Mangin, who also holds the David Braley and Nancy Gordon Chair in Family Medicine.
“Primary care and primary care research focuses on what matters most to patients,” said Dr. David Price, chair of family medicine for the Michael G. DeGroote School of Medicine. “Dee’s work is helping us to have the information we need to work collaboratively with our patients for optimal, personalized care.”
Throughout the year, the Pearls are disseminated locally, regionally and nationally by members of the NAPCRG Community Clinician Advisory Group.
One of Dr. Mangin’s awarded studies looked at whether or not early childhood iron deficiency without anemia, a relatively common condition, has an effect on brain development in children. To study this topic, Dr. Mangin and her colleagues followed nearly 500 children from birth to six years of age. They measured iron levels and a comprehensive set of other factors that could impact how a child’s brain develops.
Dr. Mangin’s second study selected for the honour looked at the continued use of selective serotonin reuptake inhibiters (SSRIs) as maintenance treatment in primary care patients with a past diagnosis of depression. Many people continue to use antidepressants on an on-going basis to prevent further episodes of depression. However, the effectiveness of this continued use had not yet been studied as a randomized controlled trial in a primary care setting before Dr. Mangin’s work.
To further illustrate the quality and importance of this work, NAPCRG chose Dr. Mangin’s iron deficiency study to represent the best North American primary care research at the Society for Academic Primary Care’s (SAPC) annual conference in Dublin this July. At the conference, Dr. Mangin will give a distinguished presentation about her research, helping to spread the results of her work internationally.